Samit Hirawat
Net worth: 2 M $ as of 30/08/2026
Net worth: 2 M $ as of 30/08/2026
Dr. Samit Hirawat, MD, is an Independent Director at Pacira Biosciences, Inc. and an Operating Partner at Jeito Capital /US/.
He is on the Board of Directors at Pacira Biosciences, Inc. Dr. Hirawat was previously employed as a Chief Medical Officer, EVP & Head-Development by Bristol Myers Squibb Co. and a Head- Global Oncology Development by Novartis AG.
He received his undergraduate degree from SMS Medical College & Hospital.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/03/2026 | 31,925 ( 0% ) | 2 M $ | 30/08/2026 | |
| 09/06/2026 | 6,405 ( 0.02% ) | 165 890 $ | 30/08/2026 |
| Companies | Position | Start |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Director/Board Member | 26/01/2026 |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Director/Board Member | 31/07/2026 |
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 31/07/2025 |
| NOVARTIS AG | Corporate Officer/Principal | 31/05/2019 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
SMS Medical College & Hospital
SMS Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
Select your edition
All financial news and data tailored to specific country editions